Serial biotech founder George Church has a new startup, and this time, he has skin in the game, quite literally.

Renowned Harvard geneticist and serial entrepreneur George Church is at it again, with a venture that has raised $75 million ...

The Federal Reserve yesterday cut interest rates by 50 basis points, in its first time cutting rates in four years. And how ...

Selling plaque psoriasis drug Vtama to Organon looks like another win for Roivant, which has been buying overlooked drugs, ...

Vanda Pharmaceuticals has failed to persuade the FDA to approve its gastroparesis candidate on the strength of a phase 3 ...

So, he truly has skin in the game,” GCTx co-founder and Chief Scientific Officer Alex Ng, Ph.D., told Fierce Biotech. “Along ...

Evonik has developed a groundbreaking model of the skin microbiome that allows for realistic, scientifically validated ...

The FDA has approved Roche's Ocrevus Zunovo for relapsing and primary progressive multiple sclerosis, offering the first ...

Alteogen overtakes EcoPro BM, South Korea’s largest producer of cathodes for EV batteries, to become the biggest company on the Kosdaq by market capitalization.

The lamellar ichthyosis market landscape is expected to evolve with increased interest from pharmaceutical companies in ...

CGMs are small patch-like wearable medical devices that use biosensor wires under the skin to measure glucose in real-time. These devices are increasingly popular in diabetes management and health ...

Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today provided an update on ...